SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932440-14-000098
Filing Date
2014-02-14
Accepted
2014-02-14 16:08:35
Documents
1
Group Members
RIDGEBACK CAPITAL INVESTMENTS LTD.RIDGEBACK CAPITAL MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sc13ga_2216947.htm SC 13G/A 154192
  Complete submission text file 0000932440-14-000098.txt   155974
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 14616439
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011
Business Address 75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011 212-624-2567
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A